Losses in the U.S. from medical technology and decreased incentives 2010-2035

This statistic displays estimated aggregate losses from medical technology in the United States within a decreased incentives scenario (in comparison to continued incentives) from 2010 to 2035. In 2020, aggregate losses due to decreased incentives within the four selected medical technology areas is expected to reach almost 60 billion U.S. dollars. The direct economic benefit of medical technology such as devices and diagnostics is simple to measure, however, including indirect costs such as reducing the length of hospital stays is more complex to find.

Estimated aggregate losses due to medical technology within a decreased incentives scenario from 2010 to 2035 (in billion U.S. dollars)*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2014

Region

United States

Survey time period

2010 to 2014

Supplementary notes

* Including medical technologies concerning diabetes, heart disease, musculoskeletal disease, and colorectal cancer.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical technology in the United Kingdom"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.